Some of the most common safety risks for patients receiving dialysis include medication safety, infections, and falls, according to Alan Kliger, MD, clinical professor of medicine at Yale University School of Medicine.
Some of the most common safety risks for patients receiving dialysis include medication safety, infections, and falls, according to Alan Kliger, MD, clinical professor of medicine at Yale University School of Medicine.
Transcript
What are the major safety risks of dialysis, and how common are they?
Patients on dialysis are complex; they have multisystem disease and therefore the possibility of problems, the possibility of errors, the possibility of safety issues is higher than for other patients. Patients on dialysis have particular areas of safety concern. First is medications; patients on dialysis often take more than 6 and sometimes more than 16 different medications, each with different time intervals, each with different indications, sometimes with interactions, and so medication safety, taking the right medicine at the right time in the right combinations, is a major safety issue for patients.
A second is infections, something that I’ve been involved with recently. Eleven percent of dialysis patients die as a direct result of infections, making it the second leading cause of death only after heart and vascular disease. And more hospital days are spent as a result of infection than cardiovascular disease. So infection and particularly preventable infections is a substantial source of safety problems for patients.
Other things include falls, which are common and often incapacitating when they result in fracture for patients on dialysis. And vascular access issues, issues around the fistula, bleeding catheter problems. So those are sort of the major risks of dialysis patients.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More